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ABSTRACT 
Objective: The aim of this investigation was to enhance the transdermal permeation of aceclofenac (ACF) from microemulsion formulation using 
menthol as a natural permeation enhancer.  
Methods: Microemulsion containing 2% w/v of ACF was prepared by a titration method with different concentration of oil, surfactant and co-
surfactant. The prepared microemulsion was evaluated for droplet size, viscosity, pH and in vitro skin permeation studies. Menthol at 3-8% w/w 
was added to the selected microemulsion formulation and their effect on skin permeation was evaluated across rat epidermis using modified 
Keshary-Chien diffusion cell. The Fourier transform infrared spectroscopy (FT-IR) was performed to understand the regulation action of menthol in 
the skin permeability barrier.  
Results: The average droplet size of the microemulsion was found to be 89.4±2.12 to 175.2±3.10 nm. The transdermal flux of the microemulsion 
containing 8% w/w menthol showed 2.9 fold increases in transdermal flux of ACF compared with the formulation without menthol. Result of FT-IR 
studies showed decrease in peak height of the symmetric and asymmetric C-H stretching vibrations may be because of the extraction of the stratum 
corneum (SC) lipids and the alteration of the skin permeability barrier. 
Conclusion: This result suggests that menthol significantly enhanced the transdermal permeation of ACF and may be an effective natural 
penetration enhancer for transdermal delivery of the drug. 
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Aceclofenac (ACF) (2-[(2, 6-dichlorophenyl) amine] phenylacetoxyacetic 
acid) is an orally effective non-steroidal anti-inflammatory drug (NSAID) 
of the phenylacetic acid group, which possesses remarkable anti-
inflammatory, analgesic, and antipyretic properties. It is used in the 
treatment of osteoarthritis and inflammatory disease of the joints [1-2]. 
The most widely cited side-effect of NSAIDs includes, gastrointestinal 
ulcer, accompanied by anemia due to the bleeding, which is also true for 
ACF. In order to avoid the gastric irritation, minimize the systemic 
toxicity and achieve a better therapeutic effect, one promising method is 
to administer the drug via skin [3-4].  
Microemulsion typically consists of oil, surfactant, co-surfactant and 
an aqueous phase, which is transparent, thermodynamically stable 
and has a droplet size<0.15 µm and does not have the tendency to 
coalesce [5-6]. Microemulsion has several advantages such as 
enhanced drug solubility, good thermodynamic stability, ease of 
manufacturing and enhancement effect on transdermal delivery 
over conventional formulation [7, 8]. Recently, more attention has 
focused on microemulsions for transdermal delivery of drugs such 
as meloxicam [9], diclofenac diethylamine [10], triptolide [11].  
On the other hand, one of the greatest obstacles in the transdermal 
route of drug delivery is the stratum corneum, since it provides a 
rate limiting step for drug absorption across the skin [12]. A popular 
technique to enhance the percutaneous absorption is the use of 
penetration enhancers that reversibly perturb the permeability 
barrier of the stratum corneum [13]. The most commonly used 
penetration enhancers include organic solvents, fatty acids and 
alcohols, terpenes and azone derivatives.  
An ideal penetration enhancer should be pharmacologically inactive 
and nonirritant for the skin, potent and cosmetically acceptable [14]. 
Menthol, a naturally occurring terpenes compound (as showed in fig. 
1) isolated from Mentha Piperita is free from toxic effects and has 
been approved as a penetration enhancer in the transdermal 
delivery of several hydrophilic and lipophilic drugs [15-17].  
 
Fig. 1: Molecular structure of menthol 
 
However, the penetration-enhancing characteristic of menthol on 
the percutaneous absorption of ACF was not yet tested. In present 
study, o/w microemulsion containing ACF have been developed to 
achieve maximum skin permeation rate of the drug through excised 
rat epidermis using menthol as a natural penetration enhancer. 
MATERIALS AND METHODS  
Materials 
ACF was a gift sample from IPCA Pharmaceutical Pvt. Ltd. (India), 
castor oil, soybean oil, olive oil, oleic acid, polyoxyethylene sorbitan 
monolaurate (tween 20), polyoxyethylene sorbitan monooleate 
(tween 80), sorbitan monooleate (span 80), ethanol, and isopropyl 
alcohol (IPA) were purchased from Merck Chemicals (Mumbai, 
India). Menthol (Aldrich Chemical, Germany), sodium bromide (Loba 
Chemie Pvt. Ltd., Mumbai, India) and chloroform (Thomas Baker 
Chemicals Pvt. Ltd., Mumbai, India) were procured and used in this 
investigation. Water was purified by double distillation in a glass 
apparatus. All other chemicals and solvents were of analytical grade.  
Methods 
Screening of oils, surfactants, and co-surfactants for microemulsion 
The solubility of ACF was investigated in various oils (castor oil, 
olive oil, soybean oil, and oleic acid), surfactants (Tween 20, Tween 
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80, Span 20) and co-surfactants (ethanol, IPA) to select a solvent 
system with good solubilizing capacity of ACF. An excess amount of 
ACF was added to 5 ml of each of the solvent and shaken at 25 °C for 
72 h to attain equilibrium. The suspension was filtered through a 
0.45 μm membrane filter and the concentration of ACF in the filtrate 
was determined by UV spectrophotometer at 273 nm. 
Construction of pseudo-ternary phase diagrams and formulation 
of ACF microemulsion 
The pseudo-ternary phase diagrams were constructed by 
installation of homogeneous liquid mixtures of oil, surfactant and co-
surfactant with water at ambient temperature [18] at S/CoS ratio of 
1:1, 2:1, 3:1 and 4:1 that resulted in large existent area of 
microemulsion containing ACF. The ratio of oil to mixture of S/CoS 
was varied from 9:1 to 1:9 and water was added drop by drop under 
continuous agitation. Usually with the addition of water to mixture 
of oils and S/CoS, the mixture become turbid at a certain point 
(beginning of phase inversion) and the turbid mixture again turned 
to clear indicating formation of O/W microemulsion. Further, 2-8% 
w/w menthol was added to the selected formulations and the skin 
permeation rate of ACF was also evaluated across rat epidermis 
using Keshary-Chien diffusion cell. 
Characterization of microemulsion 
Droplet size, pH and viscosity determination 
The average droplet size of the microemulsions were measured by 
dynamic light scattering (DLS) using a zetasizer nano-S90 (Malvern 
Instruments, England). Light scattering was monitored at 25⁰C at a 
90⁰ angle. The pH of the formulations was determined by using a pH 
meter (TOSHNIWAL, Model CL 54) at 25±1 °C. The viscosity of 
microemulsions was measured using a Brookfield rotational 
viscometer (LV2, Brookfield Inc., USA) equipped with the spindle no. 
64 at 25⁰ C. 
In vitro skin permeation study 
The abdominal hair of Wistar male albino rats (obtained from M/S 
Ghosh Enterprises, Kolkata, India and maintained under controlled 
conditions of temperature as well as humidity), weighing 150-200 g, 
was shaved using an electric razor after sacrificing with excess 
chloroform inhalation. The abdominal skin was surgically removed 
and adhering subcutaneous fat was carefully cleaned. The epidermis 
was then separated from dermis by soaking the full thickness skin in 
2 M sodium bromide solution in water for 6-8 h [19]. The epidermis 
was thoroughly washed with water, dried at 25% RH, wrapped in 
aluminium foil and stored in freeze until further use. All experiments 
with animals were approved by the institutional animal ethics 
committee of Girijananda Chowdhury Institute of Pharmaceutical 
Science (GIPS/IAEC/M. ph/2014/3) India. 
For in vitro permeation studies, skins were allowed to hydrate for 1 
h before being mounted on the Keshary-Chien diffusion cell with the 
stratum corneum (SC) with effective surface area 1.54 cm2 facing the 
donor compartment. The receptor compartment was filled with 19.5 
ml of pH 7.4 phosphate buffer and its temperature was maintained 
at 37±0.5 °C. 1 ml of microemulsion was applied on the SC side in the 
donor compartment and covered with aluminium foil to prevent 
drying out. 1 ml of receptor medium was withdrawn every hour for 
8 h after the application and replaced with an equal volume of fresh 
phosphate buffer pH 7.4 equilibrated at 37±0.5 °C. The amount of 
drug permeated was determined spectrophotometrically at 273 nm. 
Preparation of rat SC 
The rat epidermis was incubated for 4 hr with 1% (w/v) trypsin 
solution in phosphate buffer pH 7.4 at 37 °C. The tissue was then 
smoothed out on a flat surface and the mushy epidermis was 
removed by rubbing with a moist, cotton-tipped applicator. The 
transparent SC so obtained was floated briefly on water, blotted dry, 
and used in the FT-IR studies [20-21].  
FT-IR studies of rat SC 
Earlier by Casal and Mantsch [22] have established that lipid 
extraction of SC can be observed with a decrease in the C–H 
stretching absorbance intensity of FT-IR spectra of SC. In the present 
study rat SC was treated with 3-8% menthol in 25:75 ratio of an 
ethanol-water co-solvent system for 24 h. The treated SC samples 
were vacuum-dried (650 mm of Hg) at 21±1 °C for 2 d and stored in 
a desiccators to remove the traces of menthol and ethanol [23-24]. 
The completely dried samples of the SC were then subjected to FT-IR 
(Bruker Alpha, Germany) study and spectra were recorded in the 
frequency range of 400 to 4000 cm-1. 
RESULTS AND DISCUSSION 
Screening of oils and surfactants 
The results of solubility studies of ACF showed variable solubility of 
ACF in oils, surfactant and co-surfactant. The solubility of ACF was 
found to be maximum in castor oil (23.23±0.13 mg/ml) followed by 
oleic acid (4.20±2.00 mg/ml), olive oil (1.45±0.06 mg/ml) and soy 
bean oil (1.07±0.13 mg/ml). Amongst the surfactants, tween 80 
showed the maximum solubility (65.27±2.77 mg/ml) followed by 
tween 20 (10.52±1.90 mg/ml) and span 20 (6.24±0.34 mg/ml). 
Ethanol showed the highest solubility amongst the co-surfactants 
(84.56±1.43 mg/ml), followed by IPA (48.60±3.69 mg/ml). Based on 
solubility studies castor oil was chosen as oil phase, tween 80 and 
ethanol were chosen as surfactant and co-surfactant respectively to 
prepare microemulsion for ACF. 
Optimization of microemulsion formulation 
The phase diagram facilitated the determination of components 
concentration range for the existence of microemulsion. Fig. 2 
showed the phase diagrams, constructed by ProSim ternary diagram 
software, version 1.0.3 to determine the optimum surfactant to co-
surfactant ratio (S/CoS), for the formulation of O/W microemulsion 
consisting of castor oil as oil phase, tween 80 as a surfactant, ethanol 
as co-surfactant, and water. The S/CoS was varied as 1:1, 2:1, 3:1 
and 4:1. With increases in S/CoS ratio, the existence area of O/W 
microemulsion becomes enlarged and reached maximum at 4:1 
ratio. Based on this result, 4:1 ratio of S/CoS was selected to 
formulate ACF microemulsion. The detailed compositions of all 
formulations were showed in table 1. 
  
Table 1: Composition of ACF microemulsion 
F. code Components   
ACF % w/w castor oil S/CoS (tween 80/ethanol) water Menthol % w/w 
ME1 2 5 25 68 - 
ME2 2 5 50 43 - 
ME3 2 5 75 18 - 
ME4 2 10 25 63 - 
ME5 2 10 50 38 - 
ME6 2 10 75 13 - 
ME7 2 15 25 58 - 
ME8 2 15 50 33 - 
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Fig. 2: Pseudo-ternary phase diagrams of microemulsion composed of castor oil, surfactant (tween 80), co-surfactant (ethanol) and water. 
(a) S/CoS, 1:1 (b) S/CoS, 2:1 (c) S/CoS, 3:1 (d) S/CoS, 4:1 
 
Physicochemical evaluation of microemulsion 
The results of the physical parameters of all formulations were 
presented in table 2. The average size of oil droplets of 
microemulsion formulations was found to be 89.4±2.12 to 
175.2±3.10 nm. The pH of the formulations was range 6.2±0.16-
6.7±0.40 and viscosity range 71-99 cP. The results of these study 
revealed that addition of 3-8% w/w menthol in the formulation did 
not significantly changes the physicochemical properties of the 
microemulsion.
  
Table 2: Physicochemical parameters of microemulsion formulations 
Formulations pH* Particle size* (nm) Polydispersity Index Viscosity (cP) 
ME1 6.2±0.16 105.3±1.05 0.310 73 
ME2 6.3±0.05 151.2±2.15 0.255 74 
ME3 6.5±0.22 101.6±1.25 0.343 71 
ME4 6.4±0.06 170.7±1.03 0.230 82 
ME5 6.3±0.32 102.6±3.05 0.310 84 
ME6 6.6±0.05 93.5±1.50 0.255 87 
ME7 6.4±0.22 166.1±2.52 0.343 94 
ME8 6.7±0.40 152.3±1.15 0.230 98 
ME9 6.5±0.13 89.4±2.12 0.310 92 
ME10 6.3±0.23 157.4±3.05 0.324 87 
ME11 6.4±0.08 166.1±1.09 0.338 92 
ME12 6.5±0.18 175.2±3.10 0.343 99 
*(mean±SD, n=3) 
 
In vitro skin permeation study 
The skin permeation profiles of all microemulsion formulations without 
menthol (ME1 to ME9) are presented in fig. 3. The cumulative amount of 
ACF permeated through excised rat skins was plotted as a function of 
time. The slope and intercept of the linear portion of the plot were 
derived by regression. The permeation rate at steady-state (Js, µg/cm2/h) 
was calculated as the slope divided by the skin surface area. The 
intercept on the X-axis was taken as the lag time (TL, h). The permeation 
parameters calculated from the profiles are presented in table 3. 
Amongst the formulations tested, Formulation ME4 showed the 
highest permeation profile rate of ACF after 8h permeation study. 
The cumulated amount of skin permeation of ACF from this 
formulation was found to be 1492.33±10.43 µg/cm2. The content of 
S/CoS mixture in formulation affected the skin permeation of ACF 
significantly (p<0.05). As the content of S/CoS mixture was 
increased from 25 to 75% in formulations (ME4 to ME6), the skin 
permeation rate of ACF was decreased (1492.33±10.43 to 
1337.37±18.44µg/cm2). The content of oil also played an important 
role in microemulsion formulation on the skin permeation of ACF as 
showed in the fig. 3. With decrease in oil content from 15% to 5% in 
formulations ME9, ME6, ME3 the skin permeation of ACF was 
increased and the cumulative drug permeated were found 
1422.23±14.04, 1337.33±18.44µg/cm2, 1249.33±22.36, µg/cm2 
respectively after 8 h, while the content of surfactant and co-
surfactant mixture S/CoS (4:1) was fixed at 75%. This result 
suggested that, as the oil contents in the formulations decreased the 
water contents in the formulation increased which leads to hydrate 
skin and caused corneous cell to swell thus made drug channel wide, 
therefore with increasing amount of water content in the system the 
cumulative permeation amount was improved, this findings was 
supported with the previous study [25, 26]. 
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Table 3: Permeation parameters of ACF from different formulations across rat epidermis 
Formulations Permeation parameters (mean±SD, n=3) 
TL (h) Js (µg/cm2/h) 
ME1 0.86±0.23 130.41±3.12 
ME2 0.77±0.16 144.16±5.04 
ME3 0.68±0.31 156.17±3.92 
ME4 0.59±0.13 186.54±6.20 
ME5 0.73±0.24 162.79±3.30 
ME6 0.69±0.32 167.16±5.32 
ME7 0.81±0.22 146.54±3.70 
ME8 0.71±0.33 151.54±4.23 
ME9 0.64±0.62 177.79±3.55 
ME10 0.68±0.14 311.54±14.80 
ME11 0.64±0.23 424.04±5.29 
ME12 0.53±0.21 540.79±15.05 
 
 
Fig. 3: Permeation profiles of ACF through rat epidermis from microemulsions. Bar represents mean±SD (n=3) 
 
Further, to improve the permeation rate of ACF from microemulsion 
formulations menthol was added at 3% w/w, 6% w/w and 8% w/w 
in ME10, ME11 and ME12 formulations respectively. The obtained 
permeation profiles were showed in fig. 4 and the permeation 
parameters calculated from profiles were presented in table 3. The 
permeation rate (transdermal flux) of ME10, ME11 and ME12 
formulations were found to be 311.54±14.80, 424.04±5.29, 
540.79±15.05 µg/cm2/h and a lag time 0.68±0.14, 0.64±0.23, and 
0.53±0.21 h respectively, which revealed that formulation contained 
8% w/w menthol (ME12) showed the most pronounced enhancing 
effect with 2.9 fold increased in the permeation rate of ACF as 
compared to control (ME4; without menthol). 
 
 
Fig. 4: Effect of menthol on transdermal permeation of ACF through rat epidermis from microemulsions. Bar represents mean±SD (n=3) 
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FT-IR Spectroscopy of rat SC 
The FT-IR spectra of untreated rat SC showed characteristic 
absorption peaks (fig. 5A) at approximately 2852 cm-1 and 2921 cm–
1 due to symmetric and asymmetric C-H stretching vibrations of lipid 
components [27-28] and at approximately 1750-1550 cm–1 due to 
C=O stretching vibrations of an intracellular protein [29]. The FT-IR 
study showed that the treatment of SC with 3-8% concentrations of 
menthol in 25:75 ratio of the ethanol-water solvent system did not 
produce a blue shift in the asymmetric and symmetric C-H stretching 
peak positions. However, they all showed a significant decrease in 
absorbance intensities for both asymmetric and symmetric C-H 
stretching absorbance in comparison with the SC treated with 25:75 
ration of the ethanol-water solvent system considered as control 
(table 4 and fig. 5B). 8% menthol produced a greater decrease in 
peak heights for C-H stretching absorbance (asymmetric, 
55.06±0.007% and symmetric 53.88±0.006%) in comparison with 
the SC treated with 6% menthol (asymmetric, 48.41±0.008% and 
symmetric 40.29±0.007%) and 3% menthol (asymmetric, 
44.62±0.004% and symmetric 36.40±0.004%). The decrease in peak 
height may be because of the extraction of the SC lipids and this 
result is in agreement with an earlier study reported by Goats and 
Knutson, 1994 [30]. It was also reported that terpenes increase the 
drug percutaneous permeation mainly by disrupting the 
intercellular packing of the SC lipids [31, 32]. Thus, the study 
suggests that extraction of the SC lipids by menthol at 3-8% w/w 
concentration was effective for enhancing the transdermal 
permeation of ACF from microemulsion drug reservoir. 
  
Table 4: Peak height of asymmetric and symmetric C–H stretching absorbance of rat SC (mean±SD, n=3) 
Rat’s stratum corneum treated with Asymmetric C–H stretching Symmetric C–H stretching 
Peak height % Decrease in 
peak heighta 
Peak height % Decrease in 
peak heighta 
Water 3.21±0.02 ------- 2.18±0.04 ------- 
25:75 (v/v) ethanol–water solvent system 3.16±0.01 ------- 2.06±0.01 ------- 
3% w/w menthol in 25:75 (v/v) ethanol–water solvent system 1.63±0.04 48.41±0.008 1.23±0.03 40.29±0.007 
6% w/w menthol in 25:75 (v/v) ethanol–water solvent system 1.42±0.03 55.06±0.007 0.95±0.01 53.88±0.006 
8% w/w menthol in 25:75 (v/v) ethanol–water solvent system 1.75±0.05 44.62±0.004 1.31±0.06 36.40±0.004 
a%Decrease in peak height = (peak height from ethanol-water treated SC–peak height from enhancer treated SC)/peak height from ethanol-water 
treated SC × 100 [33]. 
 
 
Fig. 5A: FT-IR spectra of rat SC 
 
 
Fig. 5B: FT-IR spectra of rat SC treated with different concentration of menthol (A-without treatment, B-with 3% w/v menthol, C-with 6% 
w/v menthol, D-with 8% w/v menthol) 
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CONCLUSION 
In conclusion, an O/W microemulsion containing 2% w/v of ACF was 
prepared successfully by a titration method with different 
concentration of oil, surfactant, and co-surfactant. The in vitro skin 
permeation studies showed that menthol could markedly enhance the 
transdermal permeation of ACF from microemulsion formulation. The 
average droplet size of the microemulsion was found to be 89.4±2.12 
to 175.2±3.10 nm. The transdermal flux of the microemulsion 
containing 8% w/w menthol showed 2.9 fold increases in transdermal 
flux of ACF compared with the formulation without menthol. FT-IR 
studies revealed a decrease in peak height of the symmetric and 
asymmetric C-H stretching vibrations may be because of the extraction 
of the SC lipids and the alteration of the skin permeability barrier. This 
result suggests that menthol may be an effective natural penetration 
enhancer for transdermal delivery of ACF. 
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